Join
Live feed
·
INSIDERFilingvia Quantisnow
Charles River Laboratories International Inc. logo

Director Kemps-Polanco Reshema was granted 1,973 shares, increasing direct ownership by 76% to 4,563 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRL· Charles River Laboratories International Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRL (Charles River Laboratories International Inc.) and more on Quantisnow.